Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
31.48
-0.45 (-1.41%)
Oct 30, 2026, 4:00 PM EST - Market closed
Maze Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $110 | Buy | Maintains | $110 | +249.43% | Oct 26, 2026 |
| Citi | Citi | Buy Maintains $50 | Buy | Maintains | $50 | +58.83% | Oct 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $75 | Buy | Initiates | $75 | +138.25% | Oct 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $55 | Buy | Maintains | $55 | +74.71% | Oct 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $48 | Buy | Maintains | $48 | +52.48% | Sep 23, 2026 |
| BTIG | BTIG | Buy Maintains $46 | Buy | Maintains | $46 | +46.12% | Sep 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $57 | Buy | Maintains | $57 | +81.07% | Sep 22, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.